166
ant to first-line drugs. Antimicrob Agents
Chemother 60:2476–2483- Hu Y, Liu A, Ortega-Muro F, Alameda-Martin
L, Mitchison D, Coates A (2015) High-dose
rifampicin kills persisters, shortens treatment
duration, and reduces relapse rate in vitro and
in vivo. Front Microbiol 6:641 - Hu Y, Pertinez H, Ortega-Muro F, Alameda-
Martin L, Liu Y, Schipani A, Davies G, Coates
A (2016) Investigation of elimination rate, per-
sistent subpopulation removal, and relapse
rates of Mycobacterium tuberculosis by using
combinations of first-line drugs in a modified
Cornell mouse model. Antimicrob Agents
Chemother 60:4778–4785 - Gupta RK, Srivastava BS, Srivastava R (2010)
Comparative expression analysis of rpf-like
genes of Mycobacterium tuberculosis H37Rv
under different physiological stress and growth
conditions. Microbiology 156:2714–2722 - Tufariello JM, Jacobs WR Jr, Chan J (2004)
Individual Mycobacterium tuberculosis
resuscitation- promoting factor homologues are
dispensable for growth in vitro and in vivo.
Infect Immun 72:515–526 - Davies AP, Dhillon AP, Young M, Henderson B,
McHugh TD, Gillespie SH (2008) Resuscitation-
promoting factors are expressed in Mycobacterium
tuberculosis-infected human tissue. Tuberculosis
(Edinb) 88:462–468- Mukamolova GV, Murzin AG, Salina EG,
Demina GR, Kell DB, Kaprelyants AS,
Young M (2006) Muralytic activity of
Micrococcus luteus Rpf and its relationship to
physiological activity in promoting bacterial
growth and resuscitation. Mol Microbiol
59:84–98 - McCune RM, Feldmann FM, McDermott W
(1966) Microbial persistence. II. Characteristics
of the sterile state of tubercle bacilli. J Exp Med
123:469–486 - McCune RM, Feldmann FM, Lambert HP,
McDermott W (1966) Microbial persistence.
I. The capacity of tubercle bacilli to survive
sterilization in mouse tissues. J Exp Med
123:445–468 - Sutton S (2010) The most probable number
method and its uses in enumeration, qualifica-
tion and validation. J Valid Tech 16:4 - Grosset J, Truffot-Pernot C, Lacroix C, Ji B
(1992) Antagonism between isoniazid and the
combination pyrazinamide-rifampin against
tuberculosis infection in mice. Antimicrob
Agents Chemother 36:548–551
Yanmin Hu and Anthony Coates